TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate
Article in Clinical Microbiology and Infection (February 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Clinical Microbiology and Infection (February 2024)
Article in Biomedicines (June 2023)
Article in Cochrane Database of Systematic Reviews (May 2023)